Plakins in development and disease

Experimental Cell Research

Volumn 313, Issue 10, 2007, Pages 2189-2203

  Sonnenberg, Arnoud ^a   Liem, Ronald K H ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

BPAG; Cardiomyopathy; Cytolinker; Cytoskeleton; Desmoplakin; Epidermolysis bullosa; MACF; Muscular dystrophy; Plakin; Plectin; Spectrin

Indexed keywords

ACTIN; AUTOANTIGEN; BULLOUS PEMPHIGOID ANTIGEN 1; CYTOSKELETON PROTEIN; DESMOPLAKIN; ENVOPLAKIN; MICROTUBULE ACTIN CROSS LINKING FACTOR 1; PERIPLAKIN; PLAKIN; PLECTIN; UNCLASSIFIED DRUG;

DROSOPHILA; EMBRYO DEVELOPMENT; ENDOTHELIUM; HEART MUSCLE; HUMAN; KNOCKOUT MOUSE; MICROTUBULE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SKIN;

CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; INVERTEBRATA; MAMMALIA;

EID: 34249685610     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.03.039     Document Type: Review

References (124)

1. Ruhrberg C., and Watt F.M. The plakin family: versatile organizers of cytoskeletal architecture. Curr. Opin. Genet. Dev. 7 (1997) 392-397
2. Leung C.L., Zheng M., Prater S.M., and Liem R.K. The BPAG1 locus: alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J. Cell Biol. 154 (2001) 691-697
3. Leung C.L., Sun D., Zheng M., Knowles D.R., and Liem R.K. Microtubule actin cross-linking factor (MACF): a hybrid of dystonin and dystrophin that can interact with the actin and microtubule cytoskeletons. J. Cell Biol. 147 (1999) 1275-1286
4. Roper K., Gregory S.L., and Brown N.H. The 'spectraplakins': cytoskeletal giants with characteristics of both spectrin and plakin families. J. Cell Sci. 115 (2002) 4215-4225
5. Jefferson J.J., Leung C.L., and Liem R.K. Plakins: goliaths that link cell junctions and the cytoskeleton. Nat. Rev., Mol. Cell. Biol. 5 (2004) 542-553
6. Getsios S., Huen A.C., and Green K.J. Working out the strength and flexibility of desmosomes. Nat. Rev., Mol. Cell. Biol. 5 (2004) 271-281
7. Green K.J., Virata M.L., Elgart G.W., Stanley J.R., and Parry D.A. Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments. Int. J. Biol. Macromol. 14 (1992) 145-153
8. Koster J., Borradori L., and Sonnenberg A. Hemidesmosomes: molecular organization and their importance for cell adhesion and disease. In: Nelson J.B.A.W. (Ed). Handbook of Experimental Pharmacology: Volume Cell Adhesion (2004), Springer Verlag Gmbh C Co. KG, Berlin-Heidelberg 243-280
9. Bennett V., and Baines A.J. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol. Rev. 81 (2001) 1353-1392
10. Jefferson J.J., Ciatto C., Shapiro L., and Liem R.K. Structural analysis of the plakin domain of Bullous pemphigoid antigen1 (BPAG1) suggests that plakins are members of the spectrin superfamily. J. Mol. Biol. 366 (2007) 244-257
11. Sonnenberg A., Rojas A.M., and de Pereda J.M. The structure of a tandem pair of spectrin repeats of plectin reveals a modular organization of the plakin domain. J. Mol. Biol. 368 (2007) 1379-1391
12. O'Keefe E.J., Erickson H.P., and Bennett V. Desmoplakin I and desmoplakin II. Purification and characterization. J. Biol. Chem. 264 (1989) 8310-8318
13. Angst B.D., Nilles L.A., and Green K.J. Desmoplakin II expression is not restricted to stratified epithelia. J. Cell Sci. 97 (1990) 247-257
14. Choi H.J., Park-Snyder S., Pascoe L.T., Green K.J., and Weis W.I. Structures of two intermediate filament-binding fragments of desmoplakin reveal a unique repeat motif structure. Nat. Struct. Biol. 9 (2002) 612-620
15. Fontao L., Favre B., Riou S., Geerts D., Jaunin F., Saurat J.H., Green K.J., Sonnenberg A., and Borradori L. Interaction of the bullous pemphigoid antigen 1 (BP230) and desmoplakin with intermediate filaments is mediated by distinct sequences within their COOH terminus. Mol. Biol. Cell 14 (2003) 1978-1992
16. Stappenbeck T.S., Lamb J.A., Corcoran C.M., and Green K.J. Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J. Biol. Chem. 269 (1994) 29351-29354
17. Bornslaeger E.A., Godsel L.M., Corcoran C.M., Park J.K., Hatzfeld M., Kowalczyk A.P., and Green K.J. Plakophilin 1 interferes with plakoglobin binding to desmoplakin, yet together with plakoglobin promotes clustering of desmosomal plaque complexes at cell-cell borders. J. Cell Sci. 114 (2001) 727-738
18. Kowalczyk A.P., Bornslaeger E.A., Borgwardt J.E., Palka H.L., Dhaliwal A.S., Corcoran C.M., Denning M.F., and Green K.J. The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes. J. Cell Biol. 139 (1997) 773-784
19. Smith E.A., and Fuchs E. Defining the interactions between intermediate filaments and desmosomes. J. Cell Biol. 141 (1998) 1229-1241
20. Vasioukhin V., Bowers E., Bauer C., Degenstein L., and Fuchs E. Desmoplakin is essential in epidermal sheet formation. Nat. Cell Biol. 3 (2001) 1076-1085
21. Guo L., Degenstein L., Dowling J., Yu Q.C., Wollmann R., Perman B., and Fuchs E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 81 (1995) 233-243
22. Eger A., Stockinger A., Wiche G., and Foisner R. Polarisation-dependent association of plectin with desmoplakin and the lateral submembrane skeleton in MDCK cells. J. Cell Sci. 110 (1997) 1307-1316
23. Lechler T., and Fuchs E. Desmoplakin: an unexpected regulator of microtubule organization in the epidermis. J. Cell Biol. 176 (2007) 147-154
24. Armstrong D.K., McKenna K.E., Purkis P.E., Green K.J., Eady R.A., Leigh I.M., and Hughes A.E. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum. Mol. Genet. 8 (1999) 143-148
25. Whittock N.V., Ashton G.H., Dopping-Hepenstal P.J., Gratian M.J., Keane F.M., Eady R.A., and McGrath J.A. Striate palmoplantar keratoderma resulting from desmoplakin haploinsufficiency. J. Invest. Dermatol. 113 (1999) 940-946
26. Gallicano G.I., Kouklis P., Bauer C., Yin M., Vasioukhin V., Degenstein L., and Fuchs E. Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J. Cell Biol. 143 (1998) 2009-2022
27. Whittock N.V., Wan H., Morley S.M., Garzon M.C., Kristal L., Hyde P., McLean W.H., Pulkkinen L., Uitto J., Christiano A.M., Eady R.A., and McGrath J.A. Compound heterozygosity for non-sense and mis-sense mutations in desmoplakin underlies skin fragility/woolly hair syndrome. J. Invest. Dermatol. 118 (2002) 232-238
28. Alcalai R., Metzger S., Rosenheck S., Meiner V., and Chajek-Shaul T. A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. J. Am. Coll. Cardiol. 42 (2003) 319-327
29. Jonkman M.F., Pasmooij A.M., Pasmans S.G., van den Berg M.P., Ter Horst H.J., Timmer A., and Pas H.H. Loss of desmoplakin tail causes lethal acantholytic epidermolysis bullosa. Am. J. Hum. Genet. 77 (2005) 653-660
30. Norgett E.E., Hatsell S.J., Carvajal-Huerta L., Cabezas J.C., Common J., Purkis P.E., Whittock N., Leigh I.M., Stevens H.P., and Kelsell D.P. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet. 9 (2000) 2761-2766
31. McGrath J.A., McMillan J.R., Shemanko C.S., Runswick S.K., Leigh I.M., Lane E.B., Garrod D.R., and Eady R.A. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat. Genet. 17 (1997) 240-244
32. Herrmann H., and Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Ann. Rev. Biochem. 73 (2004) 749-789
33. Meng J.J., Bornslaeger E.A., Green K.J., Steinert P.M., and Ip W. Two-hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type-specific intermediate filaments. J. Biol. Chem. 272 (1997) 21495-21503
34. Lapouge K., Fontao L., Champliaud M.F., Jaunin F., Frias M.A., Favre B., Paulin D., Green K.J., and Borradori L. New insights into the molecular basis of desmoplakin and desmin-related cardiomyopathies. J. Cell Sci. 119 (2006) 4974-4985
35. Yang Z., Bowles N.E., Scherer S.E., Taylor M.D., Kearney D.L., Ge S., Nadvoretskiy V.V., DeFreitas G., Carabello B., Brandon L.I., Godsel L.M., Green K.J., Saffitz J.E., Li H., Danieli G.A., Calkins H., Marcus F., and Towbin J.A. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Res. 99 (2006) 646-655
36. Rampazzo A., Nava A., Malacrida S., Beffagna G., Bauce B., Rossi V., Zimbello R., Simionati B., Basso C., Thiene G., Towbin J.A., and Danieli G.A. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 71 (2002) 1200-1206
37. Gerull B., Heuser A., Wichter T., Paul M., Basson C.T., McDermott D.A., Lerman B.B., Markowitz S.M., Ellinor P.T., MacRae C.A., Peters S., Grossmann K.S., Drenckhahn J., Michely B., Sasse-Klaassen S., Birchmeier W., Dietz R., Breithardt G., Schulze-Bahr E., and Thierfelder L. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36 (2004) 1162-1164
38. Grossmann K.S., Grund C., Huelsken J., Behrend M., Erdmann B., Franke W.W., and Birchmeier W. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J. Cell Biol. 167 (2004) 149-160
39. McKoy G., Protonotarios N., Crosby A., Tsatsopoulou A., Anastasakis A., Coonar A., Norman M., Baboonian C., Jeffery S., and McKenna W.J. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355 (2000) 2119-2124
40. Ruiz P., Brinkmann V., Ledermann B., Behrend M., Grund C., Thalhammer C., Vogel F., Birchmeier C., Gunthert U., Franke W.W., and Birchmeier W. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J. Cell Biol. 135 (1996) 215-225
41. Gallicano G.I., Bauer C., and Fuchs E. Rescuing desmoplakin function in extra-embryonic ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and vasculature. Development (Cambridge, England) 128 (2001) 929-941
42. Hämmerling B., Grund C., Boda-Heggemann J., Moll R., and Franke W.W. The complexus adhaerens of mammalian lymphatic endothelia revisited: a junction even more complex than hithero thought. Cell Tissue Res. 324 (2005) 55-67
43. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanetti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Gittenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., and Dejana E. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
44. Zhou X., Stuart A., Dettin L.E., Rodriguez G., Hoel B., and Gallicano G.I. Desmoplakin is required for microvascular tube formation in culture. J. Cell Sci. 117 (2004) 3129-3140
45. Wiche G. Role of plectin in cytoskeleton organization and dynamics. J. Cell Sci. 111 (1998) 2477-2486
46. Nikolic B., Mac Nulty E., Mir B., and Wiche G. Basic amino acid residue cluster within nuclear targeting sequence motif is essential for cytoplasmic plectin-vimentin network junctions. J. Cell Biol. 134 (1996) 1455-1467
47. Borradori L., and Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J. Invest. Dermatol. 112 (1999) 411-418
48. Jones J.C., Hopkinson S.B., and Goldfinger L.E. Structure and assembly of hemidesmosomes. BioEssays 20 (1998) 488-494
49. Litjens S.H., de Pereda J.M., and Sonnenberg A. Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol. 16 (2006) 376-383
50. Geerts D., Fontao L., Nievers M.G., Schaapveld R.Q., Purkis P.E., Wheeler G.N., Lane E.B., Leigh I.M., and Sonnenberg A. Binding of integrin α6β4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J. Cell Biol. 147 (1999) 417-434
51. Koster J., Geerts D., Favre B., Borradori L., and Sonnenberg A. Analysis of the interactions between BP180, BP230, plectin and the integrin α6β4 important for hemidesmosome assembly. J. Cell Sci. 116 (2003) 387-399
52. Koster J., van Wilpe S., Kuikman I., Litjens S.H., and Sonnenberg A. Role of binding of plectin to the integrin β4 subunit in the assembly of hemidesmosomes. Mol. Biol. Cell 15 (2004) 1211-1223
53. Rezniczek G.A., de Pereda J.M., Reipert S., and Wiche G. Linking integrin α6β4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the β4 subunit and plectin at multiple molecular sites. J. Cell Biol. 141 (1998) 209-225
54. Nakano A., Pulkkinen L., Murrell D., Rico J., Lucky A.W., Garzon M., Stevens C.A., Robertson S., Pfendner E., and Uitto J. Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the β4 integrin gene (ITGB4) and genotype/phenotype correlations. Pediatr. Res. 49 (2001) 618-626
55. Pulkkinen L., Rouan F., Bruckner-Tuderman L., Wallerstein R., Garzon M., Brown T., Smith L., Carter W., and Uitto J. Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am. J. Hum. Genet. 63 (1998) 1376-1387
56. Koster J., Kuikman I., Kreft M., and Sonnenberg A. Two different mutations in the cytoplasmic domain of the integrin β4 subunit in nonlethal forms of epidermolysis bullosa prevent interaction of β4 with plectin. J. Invest. Dermatol. 117 (2001) 1405-1411
57. McLean W.H., Pulkkinen L., Smith F.J., Rugg E.L., Lane E.B., Bullrich F., Burgeson R.E., Amano S., Hudson D.L., Owaribe K., Wiche G., Pulkkinen L., Uitto J., McLean W.H., and Lane E.B. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 10 (1996) 1724-1735
58. Smith F.J., Eady R.A., Leigh I.M., McMillan J.R., Rugg E.L., Kelsell D.P., Bryant S.P., Spurr N.K., Geddes J.F., Kirtschig G., Milana G., de Bono A.G., Wiche G., Pulkkinen L., Uitto J., McLean W.H., and Lane E.B. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat. Genet. 13 (1996) 450-457
59. Andra K., Lassmann H., Bittner R., Shorny S., Fassler R., Propst F., and Wiche G. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev. 11 (1997) 3143-3156
60. Gache Y., Chavanas S., Lacour J.P., Wiche G., Owaribe K., Meneguzzi G., and Ortonne J.P. Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J. Clin. Invest. 97 (1996) 2289-2298
61. Elliott C.E., Becker B., Oehler S., Castanon M.J., Hauptmann R., and Wiche G. Plectin transcript diversity: identification and tissue distribution of variants with distinct first coding exons and rodless isoforms. Genomics 42 (1997) 115-125
62. Charlesworth A., Gagnoux-Palacios L., Bonduelle M., Ortonne J.P., De Raeve L., and Meneguzzi G. Identification of a lethal form of epidermolysis bullosa simplex associated with a homozygous genetic mutation in plectin. J. Invest. Dermatol. 121 (2003) 1344-1348
63. Fuchs P., Zorer M., Rezniczek G.A., Spazierer D., Oehler S., Castanon M.J., Hauptmann R., and Wiche G. Unusual 5′ transcript complexity of plectin isoforms: novel tissue-specific exons modulate actin binding activity. Hum. Mol. Genet. 8 (1999) 2461-2472
64. Rezniczek G.A., Abrahamsberg C., Fuchs P., Spazierer D., and Wiche G. Plectin 5′-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms. Hum. Mol. Genet. 12 (2003) 3181-3194
65. Litjens S.H., Koster J., Kuikman I., van Wilpe S., de Pereda J.M., and Sonnenberg A. Specificity of binding of the plectin actin-binding domain to β4 integrin. Mol. Biol. Cell 14 (2003) 4039-4050
66. Wilhelmsen K., Litjens S.H., Kuikman I., Tshimbalanga N., Janssen H., van den Bout I., Raymond K., and Sonnenberg A. Nesprin-3, a novel outer nuclear membrane protein, associates with the cytoskeletal linker protein plectin. J. Cell Biol. 171 (2005) 799-810
67. Andra K., Nikolic B., Stocher M., Drenckhahn D., and Wiche G. Not just scaffolding: plectin regulates actin dynamics in cultured cells. Genes Dev. 12 (1998) 3442-3451
68. Osmanagic-Myers S., Gregor M., Walko G., Burgstaller G., Reipert S., and Wiche G. Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J. Cell Biol. 174 (2006) 557-568
69. Abrahamsberg C., Fuchs P., Osmanagic-Myers S., Fischer I., Propst F., Elbe-Burger A., and Wiche G. Targeted ablation of plectin isoform 1 uncovers role of cytolinker proteins in leukocyte recruitment. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18449-18454
70. Geuijen C.A., and Sonnenberg A. Dynamics of the α6β4 integrin in keratinocytes. Mol. Biol. Cell 13 (2002) 3845-3858
71. Stegh A.H., Herrmann H., Lampel S., Weisenberger D., Andrä K., Seper M., Wiche G., Krammer P.H., and Peter M.E. Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol. Cell. Biol. 20 (2000) 5665-5679
72. Osmanagic-Myers S., and Wiche G. Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: a novel mechanism to regulate protein kinase C activity. J. Biol. Chem. 279 (2004) 18701-18710
73. Lunter P.C., and Wiche G. Direct binding of plectin to Fer kinase and negative regulation of its catalytic activity. Biochem. Biophys. Res. Commun. 296 (2002) 904-910
74. Gregor M., Zeold A., Oehler S., Marobela K.A., Fuchs P., Weigel G., Hardie D.G., and Wiche G. Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres. J. Cell Sci. 119 (2006) 1864-1875
75. Thoma-Uszynski S., Uter W., Schwietzke S., Schuler G., Borradori L., and Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J. Immunol. 176 (2006) 2015-2023
76. Brown A., Bernier G., Mathieu M., Rossant J., and Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat. Genet. 10 (1995) 301-306
77. Duchen L.W., Strich S.J., and Falconer D.S. Clinical and pathological studies of an hereditary neuropathy in mice (Dystonia musculorum). Brain 87 (1964) 367-378
78. Bernier G., Brown A., Dalpe G., De Repentigny Y., Mathieu M., and Kothary R. Dystonin expression in the developing nervous system predominates in the neurons that degenerate in dystonia musculorum mutant mice. Mol. Cell. Neurosci. 6 (1995) 509-520
79. Jefferson J.J., Leung C.L., and Liem R.K. Dissecting the sequence specific functions of alternative N-terminal isoforms of mouse bullous pemphigoid antigen 1. Exp. Cell Res. 312 (2006) 2712-2725
80. Yang Y., Bauer C., Strasser G., Wollman R., Julien J.P., and Fuchs E. Integrators of the cytoskeleton that stabilize microtubules. Cell 98 (1999) 229-238
81. Liu J.J., Ding J., Kowal A.S., Nardine T., Allen E., Delcroix J.D., Wu C., Mobley W., Fuchs E., and Yang Y. BPAG1n4 is essential for retrograde axonal transport in sensory neurons. J. Cell Biol. 163 (2003) 223-229
82. Favre B., Fontao L., Koster J., Shafaatian R., Jaunin F., Saurat J.H., Sonnenberg A., and Borradori L. The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin β4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. J. Biol. Chem. 276 (2001) 32427-32436
83. Lin C.M., Chen H.J., Leung C.L., Parry D.A., and Liem R.K. Microtubule actin crosslinking factor 1b: a novel plakin that localizes to the Golgi complex. J. Cell Sci. 118 (2005) 3727-3738
84. Claudepierre T., Manglapus M.K., Marengi N., Radner S., Champliaud M.F., Tasanen K., Bruckner-Tuderman L., Hunter D.D., and Brunken W.J. Collagen XVII and BPAG1 expression in the retina: evidence for an anchoring complex in the central nervous system. J. Comp. Neurol. 487 (2005) 190-203
85. Yang Y., Dowling J., Yu Q.C., Kouklis P., Cleveland D.W., and Fuchs E. An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 86 (1996) 655-665
86. Dalpe G., Mathieu M., Comtois A., Zhu E., Wasiak S., De Repentigny Y., Leclerc N., and Kothary R. Dystonin-deficient mice exhibit an intrinsic muscle weakness and an instability of skeletal muscle cytoarchitecture. Dev. Biol. 210 (1999) 367-380
87. Dalpe G., Leclerc N., Vallee A., Messer A., Mathieu M., De Repentigny Y., and Kothary R. Dystonin is essential for maintaining neuronal cytoskeleton organization. Mol. Cell. Neurosci. 10 (1998) 243-257
88. Sun D., Leung C.L., and Liem R.K. Characterization of the microtubule binding domain of microtubule actin crosslinking factor (MACF): identification of a novel group of microtubule associated proteins. J. Cell Sci. 114 (2001) 161-172
89. Slep K.C., Rogers S.L., Elliott S.L., Ohkura H., Kolodziej P.A., and Vale R.D. Structural determinants for EB1-mediated recruitment of APC and spectraplakins to the microtubule plus end. J. Cell Biol. 168 (2005) 587-598
90. Giorda R., Cerritello A., Bonaglia M.C., Bova S., Lanzi G., Repetti E., Giglio S., Baschirotto C., Pramparo T., Avolio L., Bragheri R., Maraschio P., and Zuffardi O. Selective disruption of muscle and brain-specific BPAG1 isoforms in a girl with a 6;15 translocation, cognitive and motor delay, and tracheo-oesophageal atresia. J. Med. Genet. 41 (2004) e71
91. Camargo L.M., Collura V., Rain J.C., Mizuguchi K., Hermjakob H., Kerrien S., Bonnert T.P., Whiting P.J., and Brandon N.J. Disrupted in schizophrenia 1 interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry 12 (2007) 74-86
92. Byers T.J., Beggs A.H., McNally E.M., and Kunkel L.M. Novel actin crosslinker superfamily member identified by a two step degenerate PCR procedure. FEBS Lett. 368 (1995) 500-504
93. Okuda T., Matsuda S., Nakatsugawa S., Ichigotani Y., Iwahashi N., Takahashi M., Ishigaki T., and Hamaguchi M. Molecular cloning of macrophin, a human homologue of Drosophila kakapo with a close structural similarity to plectin and dystrophin. Biochem. Biophys. Res. Commun. 264 (1999) 568-574
94. Sun Y., Zhang J., Kraeft S.K., Auclair D., Chang M.S., Liu Y., Sutherland R., Salgia R., Griffin J.D., Ferland L.H., and Chen L.B. Molecular cloning and characterization of human trabeculin-alpha, a giant protein defining a new family of actin-binding proteins. J. Biol. Chem. 274 (1999) 33522-33530
95. Karakesisoglou I., Yang Y., and Fuchs E. An epidermal plakin that integrates actin and microtubule networks at cellular junctions. J. Cell Biol. 149 (2000) 195-208
96. Chen H.J., Lin C.M., Lin C.S., Perez-Olle R., Leung C.L., and Liem R.K. The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. Genes Dev. 20 (2006) 1933-1945
97. Kodama A., Karakesisoglou I., Wong E., Vaezi A., and Fuchs E. ACF7: an essential integrator of microtubule dynamics. Cell 115 (2003) 343-354
98. Drabek K., van Ham M., Stepanova T., Draegestein K., van Horssen R., Sayas C.L., Akhmanova A., Ten Hagen T., Smits R., Fodde R., Grosveld F., and Galjart N. Role of CLASP2 in microtubule stabilization and the regulation of persistent motility. Curr. Biol. 16 (2006) 2259-2264
99. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., and Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
100. Ruhrberg C., Hajibagheri M.A., Parry D.A., and Watt F.M. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J. Cell Biol. 139 (1997) 1835-1849
101. Ruhrberg C., Hajibagheri M.A., Simon M., Dooley T.P., and Watt F.M. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J. Cell Biol. 134 (1996) 715-729
102. Karashima T., and Watt F.M. Interaction of periplakin and envoplakin with intermediate filaments. J. Cell Sci. 115 (2002) 5027-5037
103. Groot K.R., Sevilla L.M., Nishi K., DiColandrea T., and Watt F.M. Kazrin, a novel periplakin-interacting protein associated with desmosomes and the keratinocyte plasma membrane. J. Cell Biol. 166 (2004) 653-659
104. Aho S., Li K., Ryoo Y., McGee C., Ishida-Yamamoto A., Uitto J., and Klement J.F. Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development. Mol. Cell. Biol. 24 (2004) 6410-6418
105. Maatta A., DiColandrea T., Groot K., and Watt F.M. Gene targeting of envoplakin, a cytoskeletal linker protein and precursor of the epidermal cornified envelope. Mol. Cell. Biol. 21 (2001) 7047-7053
106. Fujiwara S., Takeo N., Otani Y., Parry D.A., Kunimatsu M., Lu R., Sasaki M., Matsuo N., Khaleduzzaman M., and Yoshioka H. Epiplakin, a novel member of the Plakin family originally identified as a 450-kDa human epidermal autoantigen. Structure and tissue localization. J. Biol. Chem. 276 (2001) 13340-13347
107. Spazierer D., Fuchs P., Proll V., Janda L., Oehler S., Fischer I., Hauptmann R., and Wiche G. Epiplakin gene analysis in mouse reveals a single exon encoding a 725-kDa protein with expression restricted to epithelial tissues. J. Biol. Chem. 278 (2003) 31657-31666
108. Jang S.I., Kalinin A., Takahashi K., Marekov L.N., and Steinert P.M. Characterization of human epiplakin: RNAi-mediated epiplakin depletion leads to the disruption of keratin and vimentin IF networks. J. Cell Sci. 118 (2005) 781-793
109. Goto M., Sumiyoshi H., Sakai T., Fassler R., Ohashi S., Adachi E., Yoshioka H., and Fujiwara S. Elimination of epiplakin by gene targeting results in acceleration of keratinocyte migration in mice. Mol. Cell. Biol. 26 (2006) 548-558
110. Spazierer D., Fuchs P., Reipert S., Fischer I., Schmuth M., Lassmann H., and Wiche G. Epiplakin is dispensable for skin barrier function and for integrity of keratin network cytoarchitecture in simple and stratified epithelia. Mol. Cell. Biol. 26 (2006) 559-568
111. Vactor D.V., Sink H., Fambrough D., Tsoo R., and Goodman C.S. Genes that control neuromuscular specificity in Drosophila. Cell 73 (1993) 1137-1153
112. Lee S., Harris K.L., Whitington P.M., and Kolodziej P.A. Short stop is allelic to kakapo, and encodes rod-like cytoskeletal-associated proteins required for axon extension. J. Neurosci. 20 (2000) 1096-1108
113. Gregory S.L., and Brown N.H. Kakapo, a gene required for adhesion between and within cell layers in Drosophila, encodes a large cytoskeletal linker protein related to plectin and dystrophin. J. Cell Biol. 143 (1998) 1271-1282
114. Prout M., Damania Z., Soong J., Fristrom D., and Fristrom J.W. Autosomal mutations affecting adhesion between wing surfaces in Drosophila melanogaster. Genetics 146 (1997) 275-285
115. Strumpf D., and Volk T. Kakapo, a novel cytoskeletal-associated protein is essential for the restricted localization of the neuregulin-like factor, vein, at the muscle-tendon junction site. J. Cell Biol. 143 (1998) 1259-1270
116. Prokop A., Uhler J., Roote J., and Bate M. The kakapo mutation affects terminal arborization and central dendritic sprouting of Drosophila motorneurons. J. Cell Biol. 143 (1998) 1283-1294
117. Bosher J.M., Hahn B.S., Legouis R., Sookhareea S., Weimer R.M., Gansmuller A., Chisholm A.D., Rose A.M., Bessereau J.L., and Labouesse M. The Caenorhabditis elegans vab-10 spectraplakin isoforms protect the epidermis against internal and external forces. J. Cell Biol. 161 (2003) 757-768
118. Roper K., and Brown N.H. Maintaining epithelial integrity: a function for gigantic spectraplakin isoforms in adherens junctions. J. Cell Biol. 162 (2003) 1305-1315
119. Lee S., and Kolodziej P.A. Short Stop provides an essential link between F-actin and microtubules during axon extension. Development 129 (2002) 1195-1204
120. Lee S., and Kolodziej P.A. The plakin Short Stop and the RhoA GTPase are required for E-cadherin-dependent apical surface remodeling during tracheal tube fusion. Development 129 (2002) 1509-1520
121. Subramanian A., Prokop A., Yamamoto M., Sugimura K., Uemura T., Betschinger J., Knoblich J.A., and Volk T. Shortstop recruits EB1/APC1 and promotes microtubule assembly at the muscle-tendon junction. Curr. Biol. 13 (2003) 1086-1095
122. Leung C.L., Green K.J., and Liem R.K. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol. 12 (2002) 37-42
123. Uitto J.J., Richard G., and McGrath J.A. Diseases of epidermal keratins and their linker proteins. Exp. Cell Res. 313 (2007) 1995-2009 this issue
124. Liu J.J., Ding J., Wu C., Bhagavatula P., Ciu B., Chu S., Mobley W.C., and Yang Y. Retrolinkin, a membrane protein, plays an important role in retrograde axonal transport. Proc. Natl. Acad. Sci. 104 (2007) 2223-2228